In a decisive step to strengthen drug regulation and protect public health, the Union Ministry of Health and Family Welfare has amended the Drugs Rules, 1945, bringing oral medicinal formulations containing high levels of ethyl alcohol under stricter controls. Effective from the recent Gazette notification issued in July 2026, medicines with more than 12 percent volume by volume (v/v) ethyl alcohol in packs larger than 30 millilitres can no longer be sold over the counter. They must now be dispensed only against a valid prescription from a registered medical practitioner and fall under the stringent Schedule H1 category.

This move targets a long-standing regulatory gap that allowed certain alcohol-based preparations — including some cough syrups, tonics, and herbal tinctures — to be available without prescription. While ethyl alcohol serves legitimate purposes in medicine as a solvent, extractant, or preservative, concerns over diversion for non-medical use, particularly intoxication, have prompted this tightening of rules. The change does not ban these medicines but ensures they reach patients only through proper medical channels and regulated pharmacies.

Background: Understanding the Regulatory Shift

India’s drug regulatory framework under the Drugs and Cosmetics Act, 1940, and the Drugs Rules, 1945, classifies medicines into various schedules based on their risk profile and need for oversight. Schedule K traditionally provided exemptions from certain licensing and sales restrictions for specific classes of drugs, including some over-the-counter items, to improve accessibility in a vast and diverse country.

However, this exemption inadvertently covered certain oral formulations with significant alcohol content. Many traditional and herbal preparations use ethyl alcohol to extract active ingredients from plants like cardamom, ginger, and other aromatics. Some of these tinctures contain alcohol concentrations as high as 80 to 90 percent, far exceeding typical medicinal levels.

In contrast, Schedule H1 — introduced in 2013 — applies to medicines requiring enhanced monitoring, such as certain antibiotics, anti-tuberculosis drugs, and habit-forming substances. Drugs under Schedule H1 cannot be sold without a prescription, and retailers must maintain detailed records of every transaction, including patient and prescriber details. These records must be preserved for at least three years and made available for inspection by drug control authorities.

The latest amendment removes the Schedule K exemption for qualifying high-alcohol oral formulations and shifts them directly into Schedule H1. This aligns with existing restrictions already in place for other systems of medicine. For instance, Rule 106B (introduced in 1994) restricts homeopathic medicines containing more than 12 percent alcohol in bottles larger than 30 ml, limiting them mostly to hospitals and dispensaries. Similarly, Ayurvedic, Siddha, and Unani syrups are capped at 16 percent alcohol under Rule 161. The new rule extends comparable safeguards to allopathic and general medicinal formulations that previously escaped such scrutiny.

What Exactly Changes Under the New Rules?

Any oral formulation — liquid or otherwise — containing more than 12% v/v ethyl alcohol and sold in quantities exceeding 30 ml is now affected. This includes various cough preparations, expectorants, tonics, and herbal extracts where alcohol is used as a base.

Key requirements post-amendment:

• Prescription mandatory: Pharmacies can dispense these medicines only on production of a valid prescription from a registered medical practitioner.
• Licensing: Manufacturers and sellers must hold appropriate licences under the Drugs and Cosmetics Act.
• Record-keeping: Chemists must log every sale with details of the patient, prescriber, quantity dispensed, and date. Separate registers are often maintained for Schedule H1 items.
• Labeling and warnings: Products carry prominent warnings, and pharmacies cannot advertise or promote them for casual use.
• No over-the-counter availability: Self-medication or easy purchase without medical advice is no longer possible for these specific formulations.

The amendment does not prohibit the manufacture or legitimate medical use of these products. Patients who genuinely need them — for example, certain cough syrups prescribed for respiratory conditions — will continue to access them through doctors. The focus is on preventing easy diversion and ensuring rational use.

Why Did the Government Act Now?

The primary driver is the growing evidence of misuse. State governments across India flagged repeated instances where high-alcohol medicinal products were being diverted for intoxication, especially among vulnerable groups including adolescents. Tinctures and aromatic preparations with extremely high alcohol content proved particularly susceptible because they were inexpensive and readily available without prescription.

Ethyl alcohol in medicines serves a functional role — it helps dissolve herbal extracts and acts as a preservative. However, when concentrations reach 80-90 percent in some traditional preparations, the risk of abuse rises sharply. Past incidents involving cough syrups and similar products, both domestically and in export markets, had already heightened regulatory vigilance.

The Ministry of Health stated that the amendment aims “to strengthen regulatory oversight over those medicinal products containing alcohol, ensuring their supply only through the regulated pharmaceutical supply chain.” References from several states highlighted the need for review, leading to recommendations from bodies like the Drugs Consultative Committee (DCC) and the Drugs Technical Advisory Board (DTAB).

Public health experts note that while most medications contain very little ethanol, certain formulations can contribute to measurable blood alcohol levels if consumed in large quantities or by sensitive individuals. Strengthening prescription controls supports better antimicrobial stewardship where relevant, reduces inappropriate self-medication, and aligns with World Health Organization principles of rational medicine use — prescribing appropriately, dispensing correctly, and using medicines only when clinically indicated.

Impact on Patients, Pharmacies, and the Industry

For patients: The biggest change is the need for a doctor’s visit or consultation before purchasing affected medicines. This may cause minor inconvenience for those accustomed to buying cough syrups directly but improves safety by ensuring proper diagnosis and dosage. Doctors may recommend alcohol-free alternatives where suitable. Patients should never combine these medicines with alcoholic beverages without medical advice, as it can amplify side effects like drowsiness or impaired coordination.

For pharmacies and chemists: Compliance now requires maintaining detailed sales registers, retaining prescriptions, and undergoing potential inspections. While this adds administrative burden, it is consistent with existing Schedule H1 protocols for antibiotics and other controlled drugs. Licensed pharmacies are already equipped to handle such requirements.

For manufacturers and the pharmaceutical industry: Companies producing high-alcohol formulations may need to review packaging sizes, obtain or update licences, and possibly reformulate some products to lower alcohol content or switch to alternative solvents. The change encourages innovation toward safer, lower-alcohol or alcohol-free versions, which could benefit long-term market positioning.

Overall, the move promotes responsible dispensing without disrupting legitimate medical access. Genuine patients will not face shortages, as prescriptions remain the standard pathway.

Expert Views and Broader Public Health Context

Health professionals have largely welcomed the decision. Regulatory experts point out that Schedule H1 status brings these products under the same protective umbrella as other medicines with abuse potential. It reinforces the principle that medicines with psychoactive or habit-forming components — even when alcohol is the vehicle — deserve closer monitoring.

Public health advocates highlight the importance of this step in India’s ongoing efforts to improve medicine safety. With a large population and varying levels of health literacy, easy availability of high-alcohol products posed risks of accidental or intentional misuse. The amendment also sends a clear signal that the government prioritises evidence-based regulation over convenience.

Internationally, many countries impose strict controls on alcohol-containing medicines, especially those with higher concentrations. India’s move brings its framework closer to global best practices while respecting the country’s unique traditional medicine landscape.

What Consumers Should Know and Do

If you or a family member uses cough syrups, tonics, or herbal preparations regularly:

• Check the label for alcohol content and pack size.
• Consult a doctor before purchasing any product that may now fall under the new rules.
• Ask your physician about alcohol-free alternatives if available.
• Never share prescribed medicines or use them beyond the recommended duration.
• Store medicines safely, away from children and vulnerable individuals.

For minor ailments, lifestyle measures and non-medicated remedies can often suffice. When medication is necessary, following medical advice ensures both efficacy and safety.

This regulatory update reflects a maturing approach to drug control in India — one that balances accessibility with accountability. As implementation rolls out across states, pharmacies and healthcare providers will adapt quickly, and patients will benefit from greater oversight.

The government’s focus remains on safeguarding public health while ensuring that essential medicines continue to reach those who need them. By curbing potential misuse of high-alcohol formulations, this amendment contributes to a safer pharmaceutical environment for all Indians.

In the coming months, further clarifications from the Central Drugs Standard Control Organisation (CDSCO) and state drug controllers are expected. Consumers are advised to stay informed through official channels and always prioritise professional medical guidance over self-medication.

This change underscores a simple yet powerful message: medicines, especially those with significant alcohol content, are tools for healing — not casual commodities. Responsible use, guided by doctors and regulated supply chains, protects individuals and communities alike. As India strengthens its healthcare framework, such proactive steps pave the way for better health outcomes nationwide.

About The Author